Fcpm Iii Services B.V. Replimune Group, Inc. Transaction History
Fcpm Iii Services B.V.
- $592 Billion
- Q4 2024
A detailed history of Fcpm Iii Services B.V. transactions in Replimune Group, Inc. stock. As of the latest transaction made, Fcpm Iii Services B.V. holds 3,970,668 shares of REPL stock, worth $55.5 Million. This represents 8.12% of its overall portfolio holdings.
Number of Shares
3,970,668
Previous 4,866,449
18.41%
Holding current value
$55.5 Million
Previous $53.3 Billion
9.85%
% of portfolio
8.12%
Previous 9.16%
Shares
3 transactions
Others Institutions Holding REPL
# of Institutions
161Shares Held
74.9MCall Options Held
38.4KPut Options Held
43.7K-
Baker Bros. Advisors LP New York, NY11MShares$154 Million1.48% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11MShares$153 Million0.02% of portfolio
-
Redmile Group, LLC San Francisco, CA4.91MShares$68.6 Million4.65% of portfolio
-
Black Rock Inc. New York, NY4.71MShares$65.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.6MShares$50.3 Million0.0% of portfolio
About Replimune Group, Inc.
- Ticker REPL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,306,700
- Market Cap $689M
- Description
- Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...